Pharmacological studies on the novel antiallergic agent HSR-609: Its effects on behavior in mice and electroencephalograms in rabbits

Japanese Journal of Pharmacology

Volumn 75, Issue 1, 1997, Pages 43-57

  Kakiuchi, Masato ^a   Ohashi, Tetsuo ^a   Tanaka, Kazuo ^a   Kamiyama, Kazuko ^a   Morikawa, Kouji ^a   Kato, Hideo ^a  

^a Abbott Japan Co Ltd   (Japan)

Author keywords

Antiallergic agent; Behavior (mouse); Central nervous system effect; Electroencephalogram (rabbit); HSR 609

Indexed keywords

3 [4 (8 FLUORO 5,11 DIHYDROBENZ[B]OXEPINO[4,3 B]PYRIDIN 11 YLIDENE)PIPERIDINO]PROPIONIC ACID; 8 FLUORO 5,11 DIHYDRO 11 (1 METHYL 4 PIPERIDYLIDENE)BENZ[B]OXEPINO[4,3 B]PYRIDINE; ANTIALLERGIC AGENT; AZELASTINE; CYPROHEPTADINE; HEXOBARBITAL; KETOTIFEN; OXATOMIDE; RESERPINE; SCOPOLAMINE; TERFENADINE; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DELTA RHYTHM; DRUG STRUCTURE; ELECTROENCEPHALOGRAM; HEART RATE; INDUCED HYPOTHERMIA; LOCOMOTION; MALE; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; RABBIT; SLEEP; SLEEP WAKING CYCLE; SLOW BRAIN WAVE; THETA RHYTHM;

EID: 0030775943     PISSN: 00215198     EISSN: None     Source Type: Journal    
DOI: 10.1254/jjp.75.43     Document Type: Article

References (33)

1. Muramatsu H, Sawanishi H, Iwasaki N, Kakiuchi M, Ohashi T, Kato H and Ito Y: Studies on zwitter-ionization of drugs. I: Synthesis and pharmacological activities of N-alkylcarboxylic acid derivatives of 4-(2-chlorodibenz[b,f][1,4]oxazepin-11-yl)-piperazine, 4-(2-chlorodibenzo[b,f][1,4]thiazepin-11-yl)piperazine, and 4-(11H-dibenz[b,e]azepin-6-yl)piperazine. Yakugaku Zasshi 112, 479-488 (1992) (Abstr in English)
2. Muramatsu H, Sawanishi H, Iwasaki N, Kakiuchi M, Ohashi T, Kato H and Ito Y: Study on zwitter-ionization of drugs. II: Synthesis and pharmacological activity of some N-[3-(5H-dibenzo[a,d]cyclohepten-5-ylidene)propyl]-N-metylamino-and N-[3-(6H-dibenz[b,e]oxepin-11-ylidene)propyl]-N-methylamino-alkanoic acid derivatives and related compounds. Chem Pharm Bull (Tokyo) 41, 1987-1993 (1993)
3. Muramatsu H, Sawanishi H, Iwasaki N, Kakiuchi M, Ohashi T, Kato H and Ito Y: Studies on zwitter-ionization of drugs. III: Synthesis and pharmacological activities of N-alkylcarboxylic acid derivatives of 1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino-[1,2-a]azepine and 2,3,4,9-tetrahydro-1H-dibenzo[3,4:6,7] cyclohepta[1,2-c]pyridine. Yakugaku Zasshi 114, 54-62 (1994) (Abstr in English)
4. Iwasaki N, Sakaguchi J, Ohashi T, Takahara E, Ogawa N, Yasuda S, Koshinaka E, Kato H, Ito Y and Sawanishi H: Amphoteric drugs. I: Synthesis and antiallergic activity of [4-(diphenylmethoxy)piperidino]-, [4-(diphenylmethyl)piperazinyl]-and [4-(diphenylmethylene)piperidino]alkanoic acid derivatives. Chem Pharm Bull (Tokyo) 42, 2276-2284 (1994)
5. Iwasaki N, Sakaguchi J, Ohashi T, Yamazaki M, Ogawa N, Yasuda S, Koshinaka E, Kato H, Ito Y and Sawanishi H: Amphoteric drugs. II: Synthesis and antiallergic activity of [4-(5H-dibenzo[a,d]cyclohepten-5-ylidene)piperidino]alkanoic acid derivatives and related compounds. Chem Pharm Bull (Tokyo) 42, 2285-2290 (1994)
6. Iwasaki N, Ohashi T, Musoh K, Nishino H, Kado N, Yasuda S, Kato H and Ito Y: Amphoteric drugs. 3: Synthesis and antiallergic activity of 3-[(5,11-dihydro[1]-benzoxepino[4,3-b]-piperidin-11-ylidene)piperidino]propionic acid derivatives and related compounds. J Med Chem 38, 496-507 (1995)
7. Musoh K, Ohashi T, Takahashi H, Iwanaga Y, Morikawa K, Kato H and Ito Y: Pharmacological studies of HSR-609, a novel amphoteric antiallergic agent (1): Effects on various allergic models. Jpn J Pharmacol 67, Suppl I, 285P (1995)
8. Kawamura K, Hosotani T, Ohashi T, Kimura T, Watanabe Y, Iwanaga Y, Morikawa K, Kato H, Ito Y and Gomi Y: Pharmacological studies of HSR-609, a novel amphoteric antiallergic agent (2): Organ specificity of antihistamine action. Jpn J Pharmacol 67, Suppl I, 285P (1995)
9. 1-receptor. Jpn J Pharmacol 73, 291-298 (1997)
10. 3H-mepyramine may predict sedative properties of psychotropic drugs. Eur J Pharmacol 60, 391-392 (1979)
11. Juniper EF, Cartier A, Trebilcock AL, Frith PA, Dolovich J and Hargreave FE: Effects of oxatomide compared with chlorpheniramine in allergic rhinoconjunctivities. Clin Allergy 11, 61-66 (1981)
12. McTavish D and Sorkin EM: Azelastine: A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential. Drugs 38, 778-800 (1989)
13. 1-receptor antagonists: Comparative tolerability and safety. Drug Safety 10, 350-380 (1994)
14. Babe KS and Serafin WE: Histamine, bradykinin, and their antagonists. In The Pharmacological Basis of Therapeutics, 9th ed, Edited by Hardman JG, Limbird LE, Molinoff PB, Ruddon RW and Gilman AG, pp 581-600, McGraw-Hill, New York (1996)
15. Irwin S: Comprehensive observational assessment: Ia. A sysquantitative procedure for assessing the behavioral and physiologic state of the mouse. Psychopharmacologia (Berlin) 13, 222-257 (1968)
16. 50. In Manual of Pharmacologic Calculations with Computer Programs, Vol 2, pp 153-159, Springer-Verlag, New York (1987)
17. Yamamoto K, Matsushita A, Sawada T, Naito Y, Yoshimura K, Takesue H, Utsumi S, Kawasaki K, Hirono S, Koshida H and Tazaki T: Pharmacology of a new sleep inducer, 1H-1,2,4-triazolyl benzophenone derivative, 450191-S (II): Sleep-inducing activity and effect on the motor system. Folia Pharmacol Jpn 84, 25-89 (1984) (Abstr in English)
18. Sawyer CH, Everett JW and Green JD: The rabbit diencephalon in stereotaxic coordinates. J Comp Neurol 101, 801-824 (1954)
19. Leza JC, Lizasoain I and Lorenzo P: Effects of antihistaminics on locomotor activity in mice: Comparison with opiate and amphetamine-induced hyperactivity. Gen Pharmacol 22, 293-296 (1991)
20. Tasaka K, Kamei C, Nakano S, Tsujimoto S and Chung YH: Effect of epinastine, a new antiallergic agent, on the central nervous system. Pharmacometrics 38, 53-62 (1989)
21. Kubo N, Shirakawa O, Kuno T and Tanaka C: Antimuscarinic effects of antihistamines: Quantitative evaluation by receptor-binding assay. Jpn J Pharmacol 43, 277-282 (1987)
22. Saito T, Fukuda T, Sukamoto T, Yoshidomi M, Morimoto Y, Shimohara K and Ito K: General pharmacology of 1-(2-ethoxyethyl)-2-(4-methyl-1-homopiperazinyl)-benzimidazole difumarate: 1st Communication: Effects on the central nervous system. Arzneimittelforschung 38, 66-69 (1988)
23. Barnett A, Taber RI and Roth FE: Activity of antihistamines in laboratory antidepressant tests. Int J Neuropharmacol 8, 73-79 (1969)
24. Kaneto H, Kaneda H, Taira K, Deguchi Y and Hanada S: Studies on the barbital-type physical dependence liability of terfenadine in mice and rats. Pharmacometrics 31, 579-586 (1986) (Abstr in English)
25. Honig PK, Woosley RL, Zamani K, Conner DP and Cantilena LR: Changes in the pharmacokinetics and electrocardiographic pharmacodynamics of terfenadine with concomitant administration of erythromycin. Clin Pharmacol Ther 52, 231-238 (1992)
26. Hobbs WR, Rall TW and Verdoorn TA: Hypnotics and sedatives; Ethanol. In The Pharmacological Basis of Therapeutics, 9th ed, Edited by Hardman JG, Limbird LE, Molinoff PB, Ruddon RW and Gilman AG, pp 361-396, McGraw-Hill, New York (1996)
27. Fügner A, Bechtel WD, Kuhn FJ and Mierau J: In vitro and in vivo studies of the non-sedating antihistamine epinastine. Arzneimittelforschung 38, 1446-1453 (1988)
28. Ongini E, Marzanatti M and Guzzon V: Comparative effects of loratadine and selected antihistamines on sleep-waking patterns in the cat. Drug Dev Res 10, 75-83 (1987)
29. Yamamoto K and Domino EF: Cholinergic agonist-antagonist interactions on neocortical and limbic EEG activation. Int J Neuropharmacol 6, 357-373 (1967)
30. Krueger JM, Obal F, Toth L, Johannsen L, Cady AB and Opp M: Sleep factors; Models concerning their multiple interactions and specificity for sleep. In Endogenous Sleep Factors, Edited by Inoué S and Krueger JM, pp 19-29, SPB Academic Publishing, Hague (1990)
31. Jouvet M: The role of monoamines and acetylcholine-containing neurons in the regulation of the sleep-waking cycle. Ergeb Physiol 64, 166-307 (1972)
32. Jouvet M: Cholinergic mechanisms and sleep. In Cholinergic Mechanisms, Edited by Waser PG, pp 455-476, Raven Press, New York (1975)
33. Lin JS, Sakai K and Jouvet M: Evidence for histaminergic arousal mechanisms in the hypothalamus of cat. Neuropharmacolgy 27, 111-122 (1988)